Corrigendum to "Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities" [Transl. Res. 265 (2024) 1-16]
Transl Res. 2024 Dec 16:276:21.
doi: 10.1016/j.trsl.2024.12.001.
Online ahead of print.
1 Molecular Mechanisms Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via GA. Amadeo, 42-20133 Milano, Italy.
2 Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
3 Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
4 Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.
5 Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
6 Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
7 Molecular Mechanisms Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via GA. Amadeo, 42-20133 Milano, Italy. Electronic address: [email protected].